T1	Chemical 44 50	7α-HCO
T10	Chemical 495 501	7α-HCO
T11	Chemical 503 515	7α,12α-diHCO
T13	Chemical 521 532	7α,27-diHCO
T14	Disease 562 566	NASH
T16	Chemical 620 629	bile acid
T17	Disease 656 660	NASH
T19	Chemical 691 697	24S-HC
T2	Chemical 88 97	bile acid
T20	Disease 733 737	NASH
T22	Chemical 739 745	24S-HC
T23	Chemical 792 803	cholesterol
T24	Chemical 890 896	24S-HC
T25	Chemical 984 1005	24-hydroxycholesterol
T26	Chemical 1035 1046	7α,24S-diHC
T28	Chemical 1059 1069	bile acids
T29	Chemical 1105 1110	24-HC
T30	Disease 1156 1160	NASH
T32	Chemical 1179 1184	24-HC
T33	Disease 1201 1205	NASH
T34	Chemical 1255 1261	24S-HC
T35	Chemical 1325 1331	24R-HC
T38	Chemical 1400 1411	7α,24S-diHC
T4	Disease 205 209	NASH
#30	AnnotatorNotes T4	DOID:0080547
T40	Disease 1537 1541	NASH
T6	Chemical 318 327	bile acid
T7	Disease 360 364	NASH
T9	Chemical 458 463	7α-HC
T3	Biomarker 139 187	serum level of 7α-HCO is significantly increased
T5	Chemical 154 160	7α-HCO
R1	Association Arg1:T3 Arg2:T4	
T8	Biomarker 263 288	mRNA expression of CYP7A1
T15	Gene-Protein 282 288	CYP7A1
#1	AnnotatorNotes T15	HGNC:2651
R2	Association Arg1:T8 Arg2:T7	
T18	Biomarker 449 558	level of 7α-HC and its downstream metabolites 7α-HCO, 7α,12α-diHCO, and 7α,27-diHCO were significantly higher
R3	Association Arg1:T18 Arg2:T14	
T12	Biomarker 604 639	upregulation of bile acid synthesis
R4	Association Arg1:T12 Arg2:T17	
T31	Biomarker 679 708	increase of 24S-HC and 24R-HC
T37	Chemical 702 708	24R-HC
R5	Association Arg1:T31 Arg2:T20	
T21	Gene-Protein 821 828	CYP46A1
#2	AnnotatorNotes T21	HGNC:2641
T41	Gene-Protein 792 819	cholesterol 24S-hydroxylase
#3	AnnotatorNotes T41	HGNC:2641
T42	Gene-Protein 1023 1030	CYP39A1
#4	AnnotatorNotes T42	HGNC:17449
T43	Gene-Protein 984 1021	24-hydroxycholesterol 7-α-hydroxylase
#5	AnnotatorNotes T43	HGNC:17449
T27	Biomarker 1105 1118	24-HC epimers
T44	Biomarker 1179 1197	24-HC accumulation
R6	Association Arg1:T44 Arg2:T33	
T36	Gene-Protein 1509 1516	CYP39A1
T39	Biomarker 1509 1533	CYP39A1 is downregulated
